Monthly dosing reduces treatment visits while maintaining established safety and efficacy1,2 Builds on RYBREVANT FASPRO™ FDA approval to deliver the simplest and fastest combination regimen for EGFR+ non-small cell lung cancer1,3-6… Read More
BCIT Foundation and INITIO Medical Group came together to celebrate BCIT’s Nuclear Medicine students and highlight the critical role industry partners play in shaping the future of healthcare in British… Read More
The company is defining a new category, providing surgeons with innovative surgical instruments and streamlined workflows for the Emergency Department (ED) and other decentralized settings Vancouver, BC – Arbutus Medical… Read More
Terry Fox-funded researchers have uncovered the mechanisms behind three unique subtypes of mismatch repair deficient high-grade gliomas. The findings provide a clearer understanding of how these tumours develop, explain why patients respond differently… Read More
Elecsys® pTau-181 test helps clinicians rule out Alzheimer’s disease by identifying patients unlikely to have amyloid pathology Now available nationwide in primary care settings for patients aged 55 and older experiencing… Read More
